Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV

Paula Munderi; Edwin Were; Anchalee Avihingsanon; Pascale A.M Mbida; Lerato Mohapi; Samba B. Moussa; Marjolein Jansen; Ceyhun Bicer; Perry Mohammed; Yvon van Delft

Crossref Citations

1. Comparison of the efficacy, safety and durability of a switch to co-formulated RPV/TDF-TAF/FTC or DTG/ABC/3TC in virologically-suppressed HIV-1-infected patients in a single Italian centre: a cohort data analysis
Filippo Lagi, Annarita Botta, Seble Tekle Kiros, Massimo Meli, Beatrice Borchi, Annalisa Cavallo, Marco Pozzi, Alessandro Bartoloni, Gaetana Sterrantino
International Journal of Antimicrobial Agents vol: 59 issue: 1 first page: 106465 year: 2022
doi: 10.1016/j.ijantimicag.2021.106465

African Online Scientific Information Systems (Pty) Ltd t/a AOSIS
Reg No: 2002/002017/07
International Tel: +27 21 975 2602
15 Oxford Street, Durbanville, Cape Town, 7550, South Africa
publishing(AT)aosis.co.za replace (AT) with @

All articles published in this journal are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license, unless otherwise stated.
Website design & content: ©2022 AOSIS (Pty) Ltd. All rights reserved. No unauthorised duplication allowed.
By continuing to use this website, you agree to our Privacy Policy, Terms of Use and Security Policy.

____________

Subscribe to our newsletter

Get specific, domain-collection newsletters detailing the latest CPD courses, scholarly research and call-for-papers in your field.

Southern African Journal of HIV Medicine | ISSN: 1608-9693 (PRINT) | ISSN: 2078-6751 (ONLINE)